BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26534998)

  • 21. The FEV1/FEV6 ratio is a good substitute for the FEV1/FVC ratio in the elderly.
    Melbye H; Medbø A; Crockett A
    Prim Care Respir J; 2006 Oct; 15(5):294-8. PubMed ID: 16979378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of The Piko-6 Portable Device for Early COPD Detection in Primary Care.
    Hidalgo Sierra V; Hernández Mezquita MÁ; Palomo Cobos L; García Sánchez M; Castellanos RD; Jodra Sánchez S; Cordovilla Pérez R; Barrueco Ferrero M
    Arch Bronconeumol (Engl Ed); 2018 Sep; 54(9):460-466. PubMed ID: 29880313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simplified COPD screening: validation of the PiKo-6® in primary care.
    Frith P; Crockett A; Beilby J; Marshall D; Attewell R; Ratnanesan A; Gavagna G
    Prim Care Respir J; 2011 Jun; 20(2):190-8, 2 p following 198. PubMed ID: 21597667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient screening for COPD using three steps: a cross-sectional study in Mexico City.
    Franco-Marina F; Fernandez-Plata R; Torre-Bouscoulet L; García-Sancho C; Sanchez-Gallen E; Martinez D; Perez-Padilla R;
    NPJ Prim Care Respir Med; 2014 May; 24():14002. PubMed ID: 24841708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis.
    Thorn J; Tilling B; Lisspers K; Jörgensen L; Stenling A; Stratelis G
    Prim Care Respir J; 2012 Jun; 21(2):159-66. PubMed ID: 22270480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Concave Shape of the Forced Expiratory Flow-Volume Curve in 3 Seconds Is a Practical Surrogate of FEV
    Li H; Liu C; Zhang Y; Xiao W
    Respir Care; 2017 Mar; 62(3):363-369. PubMed ID: 27999150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study.
    Perez-Padilla R; Wehrmeister FC; Celli BR; Lopez-Varela MV; Montes de Oca M; Muiño A; Talamo C; Jardim JR; Valdivia G; Lisboa C; Menezes AM;
    PLoS One; 2013; 8(8):e67960. PubMed ID: 23936297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of "lung age" measured by spirometry and handy electronic FEV1/FEV6 meter in pulmonary diseases.
    Toda R; Hoshino T; Kawayama T; Imaoka H; Sakazaki Y; Tsuda T; Takada S; Kinoshita M; Iwanaga T; Aizawa H
    Intern Med; 2009; 48(7):513-21. PubMed ID: 19336952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns.
    Aghili R; Kia M; Meysamie A; Aghili SM; Paknejad O
    Iran Red Crescent Med J; 2013 Feb; 15(2):152-6. PubMed ID: 23682328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different Case Finding Approaches to Optimise COPD Diagnosis: Evidence from the RADICALS Trial.
    Alotaibi N; Borg BM; Abramson MJ; Paul E; Zwar N; Russell G; Wilson S; Holland AE; Bonevski B; Mahal A; George J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1543-1554. PubMed ID: 37492489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between FEV6, FVC and VC at the diagnosis of obstructive ventilatory defect.
    Sousa CS; Coelho DB; Amorim P; Viana P; Cruz-Martins N; Drummond M
    Pulmonology; 2024; 30(2):170-173. PubMed ID: 34987020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity and Reliability of COPD-6 Device for Detecting Chronic Obstructive Pulmonary Disease in High-Risk Individuals.
    Sami R; Omidi A; Sadegh R
    Tanaffos; 2020 Jul; 19(3):201-207. PubMed ID: 33815540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV
    Kronborg T; Hangaard S; Cichosz SL; Hejlesen O
    Respir Care; 2019 Jan; 64(1):85-90. PubMed ID: 30578360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of a decreased FEV3/FEV6 ratio in symptomatic smokers with preserved lung function.
    Tenin K; Aurélien S; Daniela M; Denis C; Frédéric C
    Respir Med Res; 2022 May; 81():100891. PubMed ID: 35259578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings.
    Represas-Represas C; Fernández-Villar A; Ruano-Raviña A; Priegue-Carrera A; Botana-Rial M;
    PLoS One; 2016; 11(1):e0145571. PubMed ID: 26726887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the fixed ratio and the
    Oh DK; Baek S; Lee SW; Lee JS; Lee SD; Oh YM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():903-915. PubMed ID: 29559774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIKO-6® vs. forced spirometry in asthmatic children.
    Gochicoa-Rangel L; Larios-Castañeda PJ; Miguel-Reyes JL; Briseño DM; Flores-Campos R; Sáenz-López JA; Torre-Bouscoulet L
    Pediatr Pulmonol; 2014 Dec; 49(12):1170-6. PubMed ID: 24500941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early detection of COPD in smoking cessation outpatients].
    Rouatbi S; Mezghani S; Khalfallah M; Benzarti M
    Tunis Med; 2015 Jul; 93(7):458-64. PubMed ID: 26757504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Airflow limitation in Brazilian Caucasians: FEV1/FEV6 vs. FEV1/FVC].
    Soares AL; Rodrigues SC; Pereira CA
    J Bras Pneumol; 2008 Jul; 34(7):468-72. PubMed ID: 18695791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-session repeatability of FET and FEV6 in the general population.
    Kainu A; Lindqvist A; Sarna S; Sovijärvi A
    Clin Physiol Funct Imaging; 2008 May; 28(3):196-201. PubMed ID: 18355346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.